Agenus Analyst Ratings
H.C. Wainwright Maintains Agenus(AGEN.US) With Hold Rating
William Blair Maintains Agenus(AGEN.US) With Hold Rating
B.Riley Financial Maintains Agenus(AGEN.US) With Buy Rating, Cuts Target Price to $8
B. Riley Cuts Price Target on Agenus to $8 From $11, Keeps Buy Rating
H.C. Wainwright Maintains Agenus(AGEN.US) With Hold Rating
H.C. Wainwright Maintains Agenus(AGEN.US) With Hold Rating
Baird Maintains Agenus(AGEN.US) With Hold Rating, Cuts Target Price to $3
Baird Maintains Neutral on Agenus, Lowers Price Target to $3
Agenus Analyst Ratings
William Blair Maintains Agenus(AGEN.US) With Hold Rating
William Blair Sticks to Its Hold Rating for Agenus (AGEN)
H.C. Wainwright Maintains Agenus(AGEN.US) With Hold Rating
Agenus Analyst Ratings
H.C. Wainwright Maintains Agenus(AGEN.US) With Hold Rating
B.Riley Financial Maintains Agenus(AGEN.US) With Buy Rating, Maintains Target Price $11
H.C. Wainwright Maintains Agenus(AGEN.US) With Hold Rating
Agenus Analyst Ratings
H.C. Wainwright Maintains Agenus(AGEN.US) With Hold Rating, Maintains Target Price $7
Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX), Agenus (AGEN) and SAGE Therapeutics (SAGE)